Need professional-grade analysis? Visit stockanalysis.com
$224.58M
13.47
984
N/A
Price Chart
Risk-Adjusted Performance
Also Listed On
Prim S.A. (PRM) Price Performance
Prim S.A. (PRM) trades on Bolsa de Madrid in EUR. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at EUR13.20.
Over the past year, PRM has traded between a low of EUR9.59 and a high of EUR13.79. The stock has gained 37.6% over this period. It is currently 37.6% above its 52-week low.
Prim S.A. has a market capitalization of $224.58M, with a price-to-earnings ratio of 13.47.
About Prim S.A.
Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, newfeet, ORTHOPrim, PRIM, PRIMcare, respira PLUS, airMed, airtex, aqtivo skin, aqtivo sport, comforGel, comforGel Lady, comforSil, ESSENCIAL, mottio sport range, my PRIM Kids, Neoprair, ONE SIZE, Primespine, and OLIUM brand names. It operates PrimAcademy, an offline and digital training platform. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
Compare Prim S.A.
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- Bolsa de Madrid
- Currency
- EUR
- Country
- Spain
Financial Metrics
- Revenue (TTM)
- $251.89M
- EBITDA
- $28.16M
- Profit Margin
- 6.62%
- EPS (TTM)
- 0.98
- Book Value
- 8.09
Technical Indicators
- 52 Week High
- €13.84
- 52 Week Low
- €9.49
- 50 Day MA
- €12.94
- 200 Day MA
- €12.96
- Beta
- 0.52
Valuation
- Trailing P/E
- 13.47
- Forward P/E
- 12.06
- Price/Sales
- 0.89
- Price/Book
- 1.63
- Enterprise Value
- $216.98M